Adam T4 upgrade test article 2026-02-19

This is the summary text

This is the main content.

Bringing together expertise in infectious disease, microbiology, chemistry and machine learning, the team will receive £3.1 million in funding for three years through a new programme from The Gates Foundation, Novo Nordisk Foundation, and Wellcome.

The award highlights the continued success of the Fleming Initiative and Imperial working with multiple partners to unlock convergent science funding to tackle major global scientific challenges.

This additional funding from the Gr-ADI (Gram-Negative Antibiotic Discovery Innovator) award will expand one of the key Grand Challenges jointly announced in 2025 with GSK, the first founding partner of the Fleming Initiative, and underpins the growing global interest in this collaborative approach to AMR research.